UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

RNA-expression of adrenomedullin is increased in patients with severe COVID-19

Critical care (London, England), 2020-08, Vol.24 (1), p.527-527, Article 527

2020

Volltextzugriff (PDF)

Bioactive adrenomedullin and interleukin-6 in COVID-19: potential biomarkers of acute kidney injury and critical illness

BMC nephrology, 2024-02, Vol.25 (1), p.52-52, Article 52

2024

Volltextzugriff (PDF)

Urinary N-Terminal Pro-Brain Natriuretic Peptide Predicts Acute Kidney Injury and Severe Disease in COVID-19

Kidney & blood pressure research, 2023-01, Vol.48 (1), p.424-435

2023

Volltextzugriff (PDF)

A Pilot Trial to Compare the Long-Term Efficacy of Pulmonary Vein Isolation with High-Power Short-Duration Radiofrequency Versus Laser Energy with Rapid Ablation Mode

Journal of cardiovascular development and disease, 2023-02, Vol.10 (3), p.98

2023

Volltextzugriff (PDF)

Urinary N‐terminal pro‐brain natriuretic peptide: prognostic value in patients with acute chest pain

ESC Heart Failure, 2021-06, Vol.8 (3), p.2293-2305

2021

Volltextzugriff (PDF)

Kidney injury molecule-1 and N-acetyl-β-D-glucosaminidase in chronic heart failure: possible biomarkers of cardiorenal syndrome

European journal of heart failure, 2011-10, Vol.13 (10), p.1104-1110

2011

Volltextzugriff (PDF)

Achieving Guideline-Directed Heart Rate ControlEarly Posthospitalization

The American journal of cardiology, 2019-04, Vol.123 (7), p.1096-1100

2019

Volltextzugriff (PDF)

Kidney injury molecule-1 and N-acetyl-ß-d-glucosaminidase in chronic heart failure: possible biomarkers of cardiorenal syndrome

European journal of heart failure, 2011-10, Vol.13 (10), p.1104-1110

2011

Volltextzugriff (PDF)

N-acteyl-ß-D-glucosaminidase and kidney injury molecule-1: New predictors for long-term progression of chronic kidney disease in patients with heart failure

Nephrology (Carlton, Vic.), 2016-06, Vol.21 (6), p.490-498

2016

Volltextzugriff (PDF)

Kidney injury molecule-1: potential biomarker of acute kidney injury and disease severity in patients with COVID-19

Journal of nephrology, 2021-08, Vol.34 (4), p.1007-1018

2021

Volltextzugriff (PDF)

N-terminal pro-brain natriuretic peptide from fresh urine for the biochemical detection of heart failure and left ventricular dysfunction

European journal of heart failure, 2010-04, Vol.12 (4), p.331-337

2010

Volltextzugriff (PDF)

Dipeptidyl-peptidase 3 and IL-6: potential biomarkers for diagnostics in COVID-19 and association with pulmonary infiltrates

Clinical and experimental medicine, 2023-12, Vol.23 (8), p.4919-4935

2023

Volltextzugriff (PDF)

Protected risk stratification with the wearable cardioverter-defibrillator: results from the WEARIT-II-EUROPE registry

Clinical research in cardiology, 2021-01, Vol.110 (1), p.102-113

2021

Volltextzugriff (PDF)

Panel of emerging cardiac biomarkers contributes for prognosis rather than diagnosis in chronic heart failure

Biomarkers in medicine, 2014-07, Vol.8 (6), p.777-789

2014

Volltextzugriff (PDF)

High-sensitive troponin T in chronic heart failure correlates with severity of symptoms, left ventricular dysfunction and prognosis independently from N-terminal pro-b-type natriuretic peptide

Clinical chemistry and laboratory medicine, 2011-11, Vol.49 (11), p.1899-1906

2011

Volltextzugriff (PDF)

Correction to: Protected risk stratification with the wearable cardioverter-defibrillator: results from the WEARIT-II-EUROPE registry

Clinical research in cardiology, 2021, Vol.110 (1), p.151-151

2021

Volltextzugriff (PDF)

The role of the tubular biomarkers NAG, kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin in patients with chest pain before contrast media exposition

Biomarkers in medicine, 2019-04, Vol.13 (5), p.379-392

2019

Volltextzugriff (PDF)

High-sensitive Troponin I in acute cardiac conditions: Implications of baseline and sequential measurements for diagnosis of myocardial infarction

Atherosclerosis, 2012-05, Vol.222 (1), p.116-122

2012

Volltextzugriff (PDF)

Equal performance of novel N-terminal proBNP (Cardiac proBNP®) and established BNP (Triage BNP®) point-of-care tests

Biomarkers in medicine, 2012-12, Vol.6 (6), p.789-796

2012

Volltextzugriff (PDF)

Abstract 15446: Impact of Patient Demographics on Optimal Beta-Blocker Use After New-Onset Heart Failure: Analysis of the HF-OPT Study (Heart Failure Optimization Study)

Circulation (New York, N.Y.), 2023-11, Vol.148 (Suppl_1)

2023

Volltextzugriff (PDF)

Cyclosporine A Impairs Norepinephrine-Induced Vascular Contractility

Kidney & blood pressure research, 2012-01, Vol.35 (6), p.655-662

2012

Volltextzugriff (PDF)

Bedrohung Anthrax: Milzbrand und sein Erreger

Praxis der Naturwissenschaften - Biologie in der Schule, 2002, Vol.51 (1), p.43-45

Jungbauer, Carsten G

2002

Volltextzugriff (PDF)

Equal performance of novel N-terminal proBNP point-of-care tests

Biomarkers in medicine, 2012-12, Vol.6 (6), p.789

2012

Volltextzugriff (PDF)

Equal performance of novel N-terminal proBNP (Cardiac proBNP

Biomarkers in medicine, 2012-12, Vol.6 (6), p.789-796

2012

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(28)

Sprache

Englisch
(27)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

RNA-expression of adrenomedullin is increased in patients with severe COVID-19

Bioactive adrenomedullin and interleukin-6 in COVID-19: potential biomarkers of acute kidney injury and critical illness

Urinary N-Terminal Pro-Brain Natriuretic Peptide Predicts Acute Kidney Injury and Severe Disease in COVID-19

A Pilot Trial to Compare the Long-Term Efficacy of Pulmonary Vein Isolation with High-Power Short-Duration Radiofrequency Versus Laser Energy with Rapid Ablation Mode

Urinary N‐terminal pro‐brain natriuretic peptide: prognostic value in patients with acute chest pain

Kidney injury molecule-1 and N-acetyl-β-D-glucosaminidase in chronic heart failure: possible biomarkers of cardiorenal syndrome

Achieving Guideline-Directed Heart Rate ControlEarly Posthospitalization

Proenkephalin Improves Cardio-Renal Risk Prediction in Acute Coronary Syndromes: The KID-ACS Score

Kidney injury molecule-1 and N-acetyl-ß-d-glucosaminidase in chronic heart failure: possible biomarkers of cardiorenal syndrome

N-acteyl-ß-D-glucosaminidase and kidney injury molecule-1: New predictors for long-term progression of chronic kidney disease in patients with heart failure

Kidney injury molecule-1: potential biomarker of acute kidney injury and disease severity in patients with COVID-19

N-terminal pro-brain natriuretic peptide from fresh urine for the biochemical detection of heart failure and left ventricular dysfunction

Dipeptidyl-peptidase 3 and IL-6: potential biomarkers for diagnostics in COVID-19 and association with pulmonary infiltrates

Protected risk stratification with the wearable cardioverter-defibrillator: results from the WEARIT-II-EUROPE registry

Panel of emerging cardiac biomarkers contributes for prognosis rather than diagnosis in chronic heart failure

High-sensitive troponin T in chronic heart failure correlates with severity of symptoms, left ventricular dysfunction and prognosis independently from N-terminal pro-b-type natriuretic peptide

Correction to: Protected risk stratification with the wearable cardioverter-defibrillator: results from the WEARIT-II-EUROPE registry

The role of the tubular biomarkers NAG, kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin in patients with chest pain before contrast media exposition

High-sensitive Troponin I in acute cardiac conditions: Implications of baseline and sequential measurements for diagnosis of myocardial infarction

Equal performance of novel N-terminal proBNP (Cardiac proBNP®) and established BNP (Triage BNP®) point-of-care tests

Abstract 15446: Impact of Patient Demographics on Optimal Beta-Blocker Use After New-Onset Heart Failure: Analysis of the HF-OPT Study (Heart Failure Optimization Study)

Cyclosporine A Impairs Norepinephrine-Induced Vascular Contractility

Bedrohung Anthrax: Milzbrand und sein Erreger

Equal performance of novel N-terminal proBNP point-of-care tests

Equal performance of novel N-terminal proBNP (Cardiac proBNP

Suchergebnisse filtern